ArticleBMJ open ophthalmology2025
Impact of complications in adult anterior uveitis in a Finnish single-centre registry study.
Article in BMJ open ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyse ocular complications, their surgical treatments and risk factors in anterior uveitis (AU). METHODS AND ANALYSIS: From a single-centre registry of all adult patients with AU in 2009 (n=413), ocular complications of 641 uveitic eyes, their operative treatments and risk factors were studied comparing patients with or without complications.
resultsA total of 269 (42%) uveitic eyes and 189 (46%) patients had ocular complications. The most common complication was cataract in 217 (34%) eyes. Glaucoma was noted in 69 (11%) eyes, cystoid macular oedema in 39 (6%), posterior synechiae in 30 (5%), band keratopathy and optic disc oedema in 11 (2%), and iris atrophy and cystic corneal oedema in one eye (0.2%). Complications were typically observed in the chronic course of AU, without notable sex difference and with non-infectious aetiology. A steroid response, the course of uveitis, eye involvement, oral, subconjunctival and prophylactic dosage of steroids, methotrexate and immunosuppressants management formed significant risk factors for complication development in AU. Respectively, significant risk was also observed with the steroid response in the development of complications other than glaucoma.
conclusionsA remarkable portion of eyes affected by AU-two out of five-develop ocular complications during long follow-up. Our results highlight the significance of uveitic inflammation and its corticosteroid treatment leading to earlier onset of cataract, glaucoma and their surgical treatments. For the first time, a significant risk was observed between the number of corticosteroid responders and the development of complications, extending beyond glaucoma. The retrospective design of the study can be considered as the main limitation of the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.